| Access Dental, Pllc | |
|
1222 N Florence Ave Ste F Claremore OK 74017-3147 | |
| (918) 343-2300 | |
| (918) 342-8820 |
| Full Name | Access Dental, Pllc |
|---|---|
| Speciality | Clinic/center - Dental |
| Location | 1222 N Florence Ave, Claremore, Oklahoma |
| Authorized Official Name and Position | Justin Christopher Battle (OWNER/DENTIST) |
| Authorized Official Contact | 9183432300 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Access Dental, Pllc 1222 N Florence Ave Ste F Claremore OK 74017-3147 Ph: (918) 343-2300 | Access Dental, Pllc 1222 N Florence Ave Ste F Claremore OK 74017-3147 Ph: (918) 343-2300 |
| NPI Number | 1225297518 |
|---|---|
| Provider Enumeration Date | 06/03/2008 |
| Last Update Date | 06/03/2008 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225297518 | NPI | - | NPPES |
| 200068010-A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QD0000X | Clinic/center - Dental | 5778 (Oklahoma) | Primary |
News Archive
The discovery of a 'molecular switch' could lead to new ways of treating infections such as MRSA, and inflammatory diseases like arthritis.
An efficient and versatile compound management operation is essential for the success of all downstream processes in high throughput screening (HTS) and small molecule development. The 6th Compound Management & Integrity conference taking place September 20 - 22, 2010 will address issues concerned with improving both strategic and tactical aspects of compound management.
Arrowhead Research Corporation today announced that it has invested $1 million in its majority owned subsidiary, Calando Pharmaceuticals, and converted approximately $8M of Calando debt to Arrowhead into equity. Arrowhead now owns approximately 79% of Calando's outstanding equity.
The U.S. Food and Drug Administration today approved Pancreaze Delayed Release Capsules, a pancreatic enzyme product. It is the third such product to receive FDA approval.
Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, announced today that it has received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for nonpegylated liposomal doxorubicin (Myocet(TM)) for first-line therapy of HER2 positive metastatic breast cancer.
› Verified 3 days ago
Ali Torabi Dds Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1502 W Blue Starr Dr, Claremore, OK 74017 Phone: 918-341-4403 Fax: 918-341-4001 | |
Robert A. Gruenberg Dds Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 133 W Blue Starr Dr, Claremore, OK 74017 Phone: 918-342-3477 Fax: 918-341-9670 | |
Kevin L. Winters, Dds, Inc. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1502 W Blue Starr Dr, Claremore, OK 74017 Phone: 918-341-4403 Fax: 918-341-4001 | |
Wt Dental Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1222 N Florence, Suite B, Claremore, OK 74017 Phone: 918-341-3933 Fax: 918-342-8820 | |
Spring Dental Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1222 N Florence Ave, Claremore, OK 74017 Phone: 918-895-6568 | |
John B Henry Dds Inc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1408 N Sioux, Claremore, OK 74017 Phone: 918-342-0575 |